| OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION, INC. | AKIN GUMP STRAUSS HAUER & FELD | Q3 2019 | Medicare/Medicaid, Copyright/Patent/Trademark, Health Issues |
| SEPSIS STAKEHOLDER COALITION | AKIN GUMP STRAUSS HAUER & FELD | Q1 2019 | Medicare/Medicaid, Budget/Appropriations, Health Issues |
| OTSUKA AMERICA PHARMACEUTICAL, INC. | OTSUKA AMERICA PHARMACEUTICAL, INC. | Q4 2017 | Medical/Disease Research/Clinical Labs, Health Issues, Alcohol and Drug Abuse |
| OTSUKA AMERICA PHARMACEUTICAL, INC. | AKIN GUMP STRAUSS HAUER & FELD | Q4 2014 | Medicare/Medicaid, Health Issues |
| OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION, INC. | OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION, INC. | Q1 2015 | Medical/Disease Research/Clinical Labs, Health Issues, Alcohol and Drug Abuse |
| OTSUKA AMERICA PHARMACEUTICAL , INC. | SQUIRE PATTON BOGGS | Q2 2014 | Medicare/Medicaid, Health Issues |
| POMCO GROUP | SQUIRE PATTON BOGGS | Q2 2013 | Health Issues |
| BRISTOL-MYERS SQUIBB COMPANY | BRISTOL-MYERS SQUIBB COMPANY | Q3 2008 | Taxation/Internal Revenue Code, Medical/Disease Research/Clinical Labs, Health Issues |